Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Melasma in Two Different Dilutions: A Randomized Double-Blind Split-Face Study

Background: Melasma is an acquired hyperpigmentation disorder with multifactorial etiologies and limited response to conventional therapies. Recent evidence suggests that Botulinum Toxin A (BoNT-A) may modulate ultraviolet (UV)-induced pigmentation and offer therapeutic benefits. Objective: We sough...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Juthapa Pongklaokam, Woraphong Manuskiatti, Rungsima Wanitphakdeedecha, Pitchaya Maneeprasopchoke, Panwadee Thongjaroensirikul, Yanin Nokdhes, Rona Maria R. Abad-Constantino, Woramate Bhorntarakcharoen, Sariya Sittiwanaruk, Thanya Techapichetvanich
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2025-07-01
Reeks:	Toxins
Onderwerpen:	melasma Letibotulinum toxin A hyperpigmentation
Online toegang:	https://www.mdpi.com/2072-6651/17/7/349
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!